Former smoking as a risk factor for visual field progression in exfoliation glaucoma patients in Sweden

Abstract

Purpose The present study aimed to identify whether former smoking was a risk factor for visual field progression in exfoliation glaucoma patients. Methods Prospective nonrandomised cohort study. The study included patients diagnosed with exfoliation glaucoma. All included patients were followed for three years (± three months) with reliable visual fields. At least five reliable visual fields needed to be included in the study. Exfoliation glaucoma was defined using the European Glaucoma Society Guidelines. The visual fields were tested using the 24–2 test strategy of the Humphrey Field Analyzer. Smoking was assessed through questionnaires. Outcomes: Visual field progression. Three different approaches were used: difference in mean deviation (MD), rate of progression (ROP), and guided progression analysis (GPA). Results In total, n = 113 patients were included; among them, n = 57 were smokers. Smoking was a significant predictor for visual field progression in the three models (MD/ROP/GPA) studied ( p = 0.01/ p = 0.001/p ≤ 0.001), even adjusting for intraocular pressure (IOP). Other predictors were included in the MD model: IOP at diagnosis ( p = 0.04) and selective laser trabeculoplasty (SLT) treatment ( p = 0.01). Other predictors were in the ROP model: Visual field index ( p = 0.005), number of medications ( p = 0.001) and SLT treatment ( p = 0.001). The number of medications was another predictor in the GPA model ( p = 0.002). Conclusions Former smoking induced visual field deterioration in all models studied. Smoking status should be considered when establishing the glaucoma diagnosis. Increased glaucoma care should be provided to former smokers to slow the progression of the disease.